Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-day vonoprazan + high-dose amoxicillin dual therapy vs 14-day high-dose esomeprazole + amoxicillin dual therapy for Helicobacter pylori eradication
ChiCTR2300070475Phase 4Completed
- Sponsor
- The Affiliated Hospital of Yangzhou University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Helicobacter pylori infection comparing 10-day vonoprazan + high-dose amoxicillin dual therapy with 14-day high-dose esomeprazole + amoxicillin dual therapy (2 arms). Primary endpoint: Helicobacter pylori eradication rate. Started Mar 2023; status: completed.
02
Drugs
vonoprazanesomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300070475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070475.